Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 86%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,305
Total Claims
$632K
Drug Cost
442
Beneficiaries
$1,429
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+3%
Opioid rate vs peers
2.6% vs 2.6% avg
+34%
Cost per patient vs peers
$1,429 vs $1,068 avg
+18%
Brand preference vs peers
10.6% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.6%
Opioid Rate
246
Opioid Claims
$25K
Opioid Cost
22.4%
Long-Acting Rate
Brand vs Generic
Brand: 980 claims · $515K
Generic: 8,259 claims · $115K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 118 | $81K |
| Fluticasone/Umeclidin/Vilanter | 76 | $65K |
| Semaglutide | 43 | $63K |
| Rivaroxaban | 49 | $32K |
| Insulin Glargine,hum.Rec.Anlog | 39 | $32K |
| Oxycodone Myristate | 28 | $22K |
| Empagliflozin | 21 | $19K |
| Insulin Detemir | 30 | $19K |
| Sitagliptin Phosphate | 14 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 15 | $16K |
| Insulin Aspart | 20 | $15K |
| Mirabegron | 19 | $12K |
| Varicella-Zoster Ge/As01b/Pf | 48 | $10K |
| Insulin Glargine,hum.Rec.Anlog | 17 | $9,617 |
| Fluticasone Propionate | 21 | $6,459 |
Prescribing Profile
Patient Profile
75
Avg Age
35%
Female
1.16
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About